Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Endonovo Therapeutics Inc (ENDV)

Endonovo Therapeutics Inc (ENDV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Endonovo Therapeutics Announces Issuance of Broad Patent Covering Electromagnetic Treatment of Multiple Sclerosis

� This furthers Endonovo's strategy to commercialize and protect its Electroceutical(s)

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Announces Issuance of U.S. Patent Covering Apparatus and Method for Electromagnetic Treatment of Neurological Injury or Condition Caused by a Stroke

Issuance of U.S. Patent No. 15217855 Further Bolsters Endonovo's Intellectual Patent Portfolio

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Provides SofPulse(R) To All NFL Teams [Updated]

Endonovo Therapeutics, Inc. (OTCQB: ENDVD) ("Endonovo" or the "Company"), announced today the delivery of SofPulse evaluation units to all thirty-two National Football League ("NFL") teams.

ENDV : 0.0013 (-7.14%)
ENDVD : 1.2400 (-4.62%)
Endonovo Therapeutics Provides SofPulse(R) To All NFL Teams

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today the delivery of SofPulse evaluation units to all thirty-two National Football League ("NFL") teams.

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Announces Effective Date of Previously Announced Reverse Split of Common Stock

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today that its previously announced 1-for-1,000 reverse split of its common stock will become effective as of December...

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Announces Reverse Stock Split - UPDATE

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today it has determined to effect a 1-for-1,000 reverse stock split of the Company's issued common shares.

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Announces Reverse Stock Split

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today it has determined to effect a 1-for-1,000 reverse stock split of the Company's issued common shares.

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Reports Third Quarter 2019 Results

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today its financial results for the quarter ended September 30, 2019.

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Announces Reverse Stock Split

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced that it had filed a preliminary information statement with respect to a proposed a reverse stock split of its common...

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Appoints Dr. William Li as Strategic Advisor to the CEO

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announces it has appointed Dr. William Li as Strategic Advisor to the CEO. Dr. Li and Endonovo CEO Alan Collier will work collaboratively...

ENDV : 0.0013 (-7.14%)
Endonovo Partners with Veterans Healthcare Supply Solutions, Appoints Samir Awad, M.D., to Scientific Advisory Board

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical(R) therapeutic devices, today announces a partnership with Veterans...

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Appoints Dr. Geoffrey Abrams of Stanford University to Its Scientific Advisory Board

via NetworkWire -- Endonovo Therapeutics Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical therapeutic devices, today announces the appointment...

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Announces Second Quarter Results

via NetworkWire - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announces financial and operating results for the second quarter ended June 30, 2019.

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Inc. Featured in Exclusive NetworkNewsWire Broadcast

via NetworkNewsAudio - Endonovo Therapeutics Inc. (OTCQB: ENDV), an innovative biotechnology company and commercial-stage developer of noninvasive Electroceutical(TM) therapeutic devices, today announces...

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Appoints Dr. Peter Novak to its Scientific Advisory Board

via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical(TM) therapeutic devices, today announces the appointment...

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Appoints Dr. Steven Levin of Johns Hopkins University to Its Scientific Advisory Board

via NetworkWire - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapeutic devices, today announces the appointment...

ENDV : 0.0013 (-7.14%)
Coverage Initiated for Endonovo Therapeutics via NetworkNewsWire

via NetworkWire -- Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company developing a bioelectronic approach to regenerative medicine, today announces it has selected the corporate communications...

ENDV : 0.0013 (-7.14%)
Guitar Center, Inc. Announces Early Tender Results for Its Previously Announced Exchange Offer and Consent Solicitation Relating to Its 9.625% Senior Unsecured Notes Due 2020

Guitar Center, Inc. (the "Company") announced the early tender results for its previously announced exchange offer and consent solicitation (the "Exchange Offer") to (i) exchange its existing 9.625% Senior...

Endonovo Therapeutics Appoints Dr. Roc Alan McCarthy as a Scientific Advisory Board Member

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, that Roc Alan McCarthy, D.O. will be joining the company as a Scientific Advisory Board Member. Dr. McCarthy will help Endonovo continue to advance...

ENDV : 0.0013 (-7.14%)
Endonovo Therapeutics Announces Steven Ford as V.P. Marketing

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, Steven Ford will be joining the company as Vice President of Marketing. In his position, Mr. Ford will be responsible for growing Endonovo's...

AGN : 192.68 (-0.59%)
ENDV : 0.0013 (-7.14%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -0.35 , SEDG +2.05 , THC unch , TER -0.21 , LITE -0.79
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar